Researchers conducted a meta-analysis to determine the effectiveness of N95 respirators vs surgical masks in protecting against viral respiratory illness transmission.
This review covers the role of mucus hypersecretion in the pathogenesis of colds and flu and treatment options for mucus hypersecretion.
The expanded approval was based on data from a phase 3 study that compared Flucelvax Quadrivalent to a US-licensed comparator quadrivalent influenza vaccine.
Researchers conducted a study that compared the prevalence of COVID-19 with influenza co-infection among the general population vs hospitalized patients, as well as outcomes associated with both infections vs COVID-19 alone.
Routine annual influenza vaccination is recommended for all patients 6 months of age and older who have no medical contraindications.
The study authors obtained randomized clinical trials comparing oseltamivir, peramivir, zanamivir, and baloxavir with other active agents or placebo.
As HIV-exposed, uninfected infants have higher rates of morbidity and mortality than HIV-unexposed uninfected infants, a study was conducted to analyze whether particular infections or immune responses contribute to hospitalization.
The researchers tested their hypothesis that a decrease in respiratory virus incidence would be associated with a reduction in inappropriate ambulatory antibiotic orders.
The 2020-21 flu season was historically low because of mitigating strategies applied to prevent the spread of COVID-19.
The bioelectronic device was previously approved for treating sinus pain due to allergic rhinitis.
